MOORESTOWN, N.J., Oct. 31, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ('TRHC' or the 'Company') (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based organizations, today announced that its stockholders approved the previously announced acquisition by Nautic Partners ('Nautic'), following which TRHC is expected to combine with ExactCare Pharmacy, a portfolio company of Nautic.

新泽西州MOORESTOWN，2023年10月31日/PRNewswire/--Tabula Rasa HealthCare，Inc.®（'TRHC'或'公司'）（纳斯达克股票代码：TRHC），一家领先的医疗保健公司，为基于价值的组织提供个性化，全面的护理，今天宣布其股东批准了Nautic Partners先前宣布的收购（'Nautic'），随后，TRHC预计将与Nautic的组合公司ExactCare Pharmacy结合使用。

The proposal to adopt the merger agreement was approved at a virtual special meeting of the Company's stockholders held today with approximately 99.6% of the votes cast in favor of the proposal, which represented approximately 70.9% of the outstanding shares of Company common stock..

通过合并协议的提案在今天举行的公司股东虚拟特别会议上获得批准，其中约99.6%的投票赞成该提案，约占公司普通股未发行股份的70.9%。。

'We are happy to have the strong support of Tabula Rasa's stockholders who recognize the value of bringing us together with Nautic's ExactCare portfolio company to advance our ability to partner with risk-bearing healthcare organizations serving those with complex care needs,' said Brian Adams, President and CEO of TRHC.

“我们很高兴得到Tabula Rasa股东的大力支持，他们认识到将我们与Nautic的ExactCare投资组合公司一起提升我们与服务于复杂护理需求的风险医疗保健组织合作的能力，”Brian Adams说，TRHC总裁兼首席执行官。

'This combination will extend our reach and position us to take advantage of existing and emerging opportunities within and adjacent to our core PACE market.'.

“这种组合将扩大我们的影响力，使我们能够利用核心步伐市场内部和附近的现有和新兴机会。”。

The Company expects to complete the transaction during the fourth quarter of 2023, subject to customary closing conditions. Upon closing, Tabula Rasa will become a privately held company and shares of TRHC common stock will no longer be listed on the Nasdaq stock exchange.

根据习惯性结算条件，公司预计将在2023年第四季度完成交易。结束后，Tabula Rasa将成为私营公司，TRHC普通股股份将不再在纳斯达克证券交易所上市。

About Tabula Rasa HealthCare

关于Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) enables simplified and individualized care that improves the health of those we serve. We offer comprehensive pharmacy services that include personalized, precision medication management and delivery as well as a suite of clinical and business management tools that help health plans and at-risk provider groups maximize revenue, optimize utilization and improve patient health.

Tabula Rasa HealthCare（TRHC）（纳斯达克股票代码：TRHC）可以实现简化和个性化的护理，从而改善我们所服务人员的健康状况。我们提供全面的药房服务，包括个性化，精确的药物管理和交付，以及一套临床和业务管理工具，帮助健康计划和风险提供者群体最大限度地增加收入，优化利用率并改善患者健康状况。

For more information, visit tabularasahealthcare.com..

欲了解更多信息，请访问tabularasahealthcare.com。。

About ExactCare

关于ExactCare

ExactCare, a national medication management and pharmacy care provider, delivers solutions to help people with complex, chronic medical needs overcome medication-related and chronic care challenges. Founded in 2009, the company enables better health for patients and better clinical, quality and economic outcomes for the healthcare organizations that care for them—including payers, home health organizations, primary care practices and other providers.

ExactCare是一家全国药物管理和药房护理提供者，提供解决方案，帮助具有复杂慢性医疗需求的人克服与药物相关的慢性护理挑战。该公司成立于2009年，为患者提供更好的健康服务，为照顾他们的医疗机构（包括付款人，家庭卫生组织，初级保健实践和其他提供者）提供更好的临床，质量和经济成果。

ExactCare provides comprehensive long-term pharmacy care to patients in assisted and independent living facilities, through transitions of care, and in their homes—with a focus on improving patient adherence to prescribed medications and enabling safer, more effective medication regimens. ExactCare also provides a number of value-based solutions, including HEDIS Gap Closure Assistance and Medication Therapy Management (MTM) Programs.

ExactCare通过护理过渡以及在家中为辅助和独立生活设施中的患者提供全面的长期药房护理，重点是改善患者对处方药的依从性并实现更安全，更有效的药物治疗方案。ExactCare还提供许多基于价值的解决方案，包括HEDIS差距缩小援助和药物治疗管理（MTM）计划。

For more information, visit exactcare.com..

欲了解更多信息，请访问exactcare.com。。

About Nautic Partners

关于Nautic Partners

Nautic Partners is a Providence, Rhode Island-based middle-market private equity firm that focuses our expertise and market knowledge on three sectors: Healthcare, Industrials and Services. Nautic has completed 155 platform transactions throughout our 37-year history. In pursing our thematic and proactive investment strategy, we seek to partner with executives and management teams in an effort to accelerate the growth trajectory of our portfolio companies via acquisitions, targeted operating initiatives, and increased management team depth.

Nautic Partners是一家位于罗德岛州普罗维登斯的中间市场私募股权公司，专注于三个部门的专业知识和市场知识：医疗保健，工业和服务。Nautic在我们37年的历史中完成了155次平台交易。在制定我们的主题和积极主动的投资战略时，我们寻求与高管和管理团队合作，通过收购，有针对性的运营计划和增加管理团队深度来加速我们投资组合公司的发展轨迹。

For more information, please visit www.nautic.com..

欲了解更多信息，请访问www.nautic.com。。

Forward-Looking Statements

前瞻性声明

This communication contains 'forward-looking statements' that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The statements contained in this communication that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ('Securities Act'), and Section 21E of the Securities Exchange Act of 1934, as amended ('Exchange Act').

本通信包含涉及风险和不确定性的“前瞻性声明”，以及假设如果它们从未实现或证明不正确，可能导致我们的结果与此类前瞻性声明所表达或暗示的结果大不相同。本通信中包含的并非纯粹历史性的陈述是1933年“证券法”第27A条（经修订）（“证券法”）和1934年“证券交易法”第21E条含义范围内的前瞻性陈述。，经修订（'交易所法'）。

Forward-looking statements are often identified by the use of words such as, but not limited to, 'anticipate,' 'believe,' 'can,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'will,' 'plan,' 'project,' 'seek,' 'should,' 'target,' 'would,' and similar expressions or variations intended to identify forward-looking statements..

前瞻性陈述通常通过使用诸如但不限于“预期”，“相信”，“可以”，“继续”，“可以”，“估计”，“期望”，“意图”，“可能”，“可能”，“计划”，“项目”，“寻求”，“应该”，“目标”，“将会”以及旨在识别前瞻性陈述的类似表达式或变体。。

These statements are based on the beliefs and assumptions of TRHC's management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements..

这些陈述基于TRHC管理层基于当前可供管理层使用的信息的信念和假设。此类前瞻性陈述受风险，不确定性和其他可能导致实际结果和某些事件发生时间与此类前瞻性陈述所表达或暗示的未来结果大不相同的重要因素的约束。。

Factors that could cause or contribute to such differences include but are not limited to the following: (i) the risk that the proposed transaction may not be completed in a timely manner or at all; (ii) the possibility that any or all of the various conditions to the consummation of the proposed transaction may not be satisfied or waived, including the failure to receive any required regulatory approvals from any applicable governmental entities (or any conditions, limitations or restrictions placed on such approvals); (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive transaction agreement relating to the proposed transaction, including in circumstances which would require TRHC to pay a termination fee; (iv) the effect of the announcement or pendency of the proposed transaction on TRHC ability to attract, motivate or retain key executives and employees, its ability to maintain relationships with its customers, vendors, service providers and others with whom it does business, or its operating results and business generally; (v) risks related to the proposed transaction diverting management's attention from TRHC's ongoing business operations; (vi) the risk of stockholder litigation in connection with the proposed transaction, including resulting expense or delay; and (vii) (A) any other risks discussed in Part I, Item 1A, 'Risk Factors' in the TRHC's most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and (B) other risk factors identified from time to time in other filings with the SEC.

可能导致或促成此类差异的因素包括但不限于以下因素：（i）拟议交易可能无法及时或根本完成的风险；（ii）可能无法满足或放弃完成拟议交易的任何或所有各种条件，包括未能获得任何适用政府实体的任何必要的监管批准（或任何条件，限制或限制对这些批准）；（iii）发生任何可能导致终止与拟议交易有关的最终交易协议的事件，变更或其他情况，包括要求TRHC支付终止费的情况；（iv）拟议交易的公告或暂停对TRHC吸引，激励或留住主要高管和员工的能力，与其客户，供应商，服务提供商及其与其业务相关人员的关系的能力的影响，或其操作结果和业务一般；（v） 与拟议交易相关的风险将管理层的注意力转移到TRHC正在进行的业务运营中；（vi）与拟议交易有关的股东诉讼风险，包括由此产生的费用或延误；（vii）（A）第一部分第1A项中讨论的任何其他风险，2022年12月31日财政年度TRHC最新表格10-K年度报告中的“风险因素”，以及（B）其他风险因素不时与SEC提交其他文件。

Filings with the SEC are available on the SEC's website at http://www.sec.gov..

与美国证券交易委员会的文件可以在美国证券交易委员会的网站上找到http://www.sec.gov..

Actual results could differ materially from those anticipated in the forward-looking statements. TRHC disclaims any obligation to update publicly any forward-looking statements, whether in response to new information, future events or otherwise, except as required by applicable law.

实际结果可能与前瞻性声明中预期的结果大不相同。除适用法律要求外，TRHC不承担任何公开更新任何前瞻性声明的义务，无论是针对新信息，未来事件还是其他方面。

SOURCE Tabula Rasa HealthCare, Inc.

来源：Tabula Rasa HealthCare，股份有限公司。